Lipemia retinalis in setting of asparaginase and glucocorticoid therapy preceding acute pancreatitis
Lipemia retinalis may serve as an early ophthalmic marker of chemotherapy-induced hypertriglyceridemia, particularly in the setting of combined glucocorticoid and asparaginase therapy. Prompt recognition is critical, as it can precede life-threatening complications such as acute pancreatitis and guide timely modifications in treatment.
Authors
- Karim Dirani (ORCID: https://orcid.org/0000-0002-8342-9579)
- Pradeepa Yoganathan (ORCID: https://orcid.org/0000-0002-4041-4297)
- Brittany Hodges
- Michael J Yu
Institutions
- Western University (CA)
- University of Toronto (CA)
- Kresge Eye Institute (US)
- University of Rochester (US)
- University of Windsor (CA)
Publication Details
- Journal
- Retinal Cases & Brief Reports
- Published
- 2026-01-21
- DOI
- https://doi.org/10.1097/icb.0000000000001875
- Primary Topic
- Lipid metabolism and disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00